LD-Oncologic
ActiveSummary
LD-Oncologic has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €140,314 and a net result of €39,623. Equity is growing by about 30% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.1% (very low).
Directors
Directors
2 directors, last change in 2024
Christophe LONCHAY
CurrentDirector (not named in the articles) · since 04-01-2024
Virginie DI SILVERIO
CurrentDirector (not named in the articles) · since 04-01-2024
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
2 of this company's 3 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
2 people since 2024, 2 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Christophe LONCHAY |
|
| Virginie DI SILVERIO |
|
Owners and capital
Capital and shareholders
Capital over the years
- 04-01-2024 Converted to unavailable equity